Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derron A Alves

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Vaccine|December 9, 2023
SARS-CoV-2 mucosal vaccine protects against clinical disease with sex bias in efficacyYongjun Sui, Hanne Andersen, Jianping Li, et al.
Emerging Infectious Diseases|February 21, 2025
Sudan Virus Persistence in Immune-Privileged Organs of Nonhuman Primate SurvivorsBrittany B Beavis, Jun Liu, Elizabeth E Zumbrun, et al.
Veterinary Parasitology|June 20, 2019
Histologically, immunohistochemically, ultrastructurally, and molecularly confirmed neosporosis abortion in an aborted equine fetusJoseph A Anderson, Derron A Alves, Camila K Cerqueira-Cézar, et al.
Irish Veterinary Journal|October 26, 2016
Dermatosparaxis in two Limousin calvesCatherine I Carty, Alison M Lee, Nathan A E Wienandt, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Bone marrow B cell collapse promotes bone metastasis in breast cancerAna Teijeiro, Claudia A Rivera, Motoyoshi Nagai, et al.
Journal of Leukocyte Biology|November 28, 2024
Cxcl10 is protective during mouse-adapted SARS-CoV-2 infectionShamik Majumdar, Joseph D Weaver, Sergio M Pontejo, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
Cxcl10 is required for survival during SARS-CoV-2 infection in miceShamik Majumdar, Joseph D Weaver, Sergio M Pontejo, et al.
Frontiers in Immunology|October 17, 2022
Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virusMallory L Myers, John R Gallagher, De'Marcus D Woolfork, et al.
Frontiers in Immunology|September 29, 2023
Corrigendum: Impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virusMallory L Myers, John R Gallagher, De'Marcus D Woolfork, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2024
Structure-guided assembly of an influenza spike nanobicelle vaccine provides pan H1 intranasal protectionMallory L Myers, John R Gallagher, De'Marcus D Woolfork, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Vaccine|December 9, 2023
SARS-CoV-2 mucosal vaccine protects against clinical disease with sex bias in efficacyYongjun Sui, Hanne Andersen, Jianping Li, et al.
Emerging Infectious Diseases|February 21, 2025
Sudan Virus Persistence in Immune-Privileged Organs of Nonhuman Primate SurvivorsBrittany B Beavis, Jun Liu, Elizabeth E Zumbrun, et al.
Veterinary Parasitology|June 20, 2019
Histologically, immunohistochemically, ultrastructurally, and molecularly confirmed neosporosis abortion in an aborted equine fetusJoseph A Anderson, Derron A Alves, Camila K Cerqueira-Cézar, et al.
Irish Veterinary Journal|October 26, 2016
Dermatosparaxis in two Limousin calvesCatherine I Carty, Alison M Lee, Nathan A E Wienandt, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Bone marrow B cell collapse promotes bone metastasis in breast cancerAna Teijeiro, Claudia A Rivera, Motoyoshi Nagai, et al.
Journal of Leukocyte Biology|November 28, 2024
Cxcl10 is protective during mouse-adapted SARS-CoV-2 infectionShamik Majumdar, Joseph D Weaver, Sergio M Pontejo, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
Cxcl10 is required for survival during SARS-CoV-2 infection in miceShamik Majumdar, Joseph D Weaver, Sergio M Pontejo, et al.
Frontiers in Immunology|October 17, 2022
Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virusMallory L Myers, John R Gallagher, De'Marcus D Woolfork, et al.
Frontiers in Immunology|September 29, 2023
Corrigendum: Impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virusMallory L Myers, John R Gallagher, De'Marcus D Woolfork, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2024
Structure-guided assembly of an influenza spike nanobicelle vaccine provides pan H1 intranasal protectionMallory L Myers, John R Gallagher, De'Marcus D Woolfork, et al.
Pageof 5